Obesity-Associated Dyslipidemia Is Moderated by Habitual Intake of Marine-Derived n-3 Polyunsaturated Fatty Acids in Yup'ik Alaska Native People: A Cross-Sectional Mediation-Moderation Analysis.

[1]  Victor Zhong,et al.  Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018. , 2021, JAMA.

[2]  A. Sinclair,et al.  Effects of dietary eicosapentaenoic acid and docosahexaenoic acid supplementation on metabolic syndrome: A systematic review and meta-analysis of data from 33 randomized controlled trials. , 2021, Clinical nutrition.

[3]  M. Chiumente,et al.  Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis , 2020, European journal of hospital pharmacy : science and practice.

[4]  J. Krakoff,et al.  Associations of plasma, RBCs, and hair carbon and nitrogen isotope ratios with fish, meat, and sugar-sweetened beverage intake in a 12-wk inpatient feeding study. , 2019, The American journal of clinical nutrition.

[5]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[6]  S. Pham,et al.  Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial , 2019, Cardiovascular Diabetology.

[7]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[8]  F. Song,et al.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[9]  R. Eckel,et al.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review , 2018, Current Diabetes Reports.

[10]  Philip C. Calder,et al.  The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review , 2018, International journal of molecular sciences.

[11]  A. Gotto,et al.  Effect of fibrates on glycemic parameters: A systematic review and meta‐analysis of randomized placebo‐controlled trials , 2017, Pharmacological research.

[12]  B. Meyer,et al.  Effects of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation on Cardiovascular Mortality: The Importance of the Dose of DHA , 2017, Nutrients.

[13]  L. Videla,et al.  Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  D. O'Brien,et al.  Declines in traditional marine food intake and vitamin D levels from the 1960s to present in young Alaska Native women , 2016, Public Health Nutrition.

[15]  N. Salem,et al.  Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. , 2016, Progress in lipid research.

[16]  B. Howard,et al.  Prevalence of Hypertension and Associated Risk Factors in Western Alaska Native People: The Western Alaska Tribal Collaborative for Health (WATCH) Study , 2015, Journal of clinical hypertension.

[17]  B. Howard,et al.  Cardiometabolic correlates of low type 2 diabetes incidence in western Alaska Native people - The WATCH study. , 2015, Diabetes research and clinical practice.

[18]  B. Howard,et al.  Sex differences in obesity prevalence and cardiometabolic factors among Western Alaska Native people. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[19]  T. Vasankari,et al.  A universal, accurate intensity‐based classification of different physical activities using raw data of accelerometer , 2015, Clinical physiology and functional imaging.

[20]  A. Kristal,et al.  A stable isotope biomarker of marine food intake captures associations between n-3 fatty acid intake and chronic disease risk in a Yup'ik study population, and detects new associations with blood pressure and adiponectin. , 2014, The Journal of nutrition.

[21]  B. Klop,et al.  Dyslipidemia in Obesity: Mechanisms and Potential Targets , 2013, Nutrients.

[22]  W. Harris,et al.  Fish oil -- how does it reduce plasma triglycerides? , 2012, Biochimica et biophysica acta.

[23]  T. A. Jacobson,et al.  Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis , 2011, Current atherosclerosis reports.

[24]  A. Kristal,et al.  Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids , 2011, European Journal of Clinical Nutrition.

[25]  L. Keele,et al.  A General Approach to Causal Mediation Analysis , 2010, Psychological methods.

[26]  Y. Deshaies,et al.  PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity. , 2010, Molecular nutrition & food research.

[27]  A. Kristal,et al.  Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. , 2010, The American journal of clinical nutrition.

[28]  D. Jacobs,et al.  Food synergy: an operational concept for understanding nutrition. , 2009, The American journal of clinical nutrition.

[29]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[30]  A. Kristal,et al.  Red blood cell delta15N: a novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake. , 2009, The American journal of clinical nutrition.

[31]  P. Kris-Etherton,et al.  N-3 fatty acids: food or supplements? , 2008, Journal of the American Dietetic Association.

[32]  B. Fagerberg,et al.  Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance , 2008 .

[33]  S. Ishibashi,et al.  New Insights on the Simultaneous Assessment of Insulin Sensitivity and β-Cell Function With the HOMA2 Method , 2007, Diabetes Care.

[34]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[35]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[36]  R. Russell,et al.  Essential nutrients: food or supplements? Where should the emphasis be? , 2005, JAMA.

[37]  Ken Williams,et al.  Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis Study , 2005, Circulation.

[38]  M. Quon,et al.  Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia. , 2005, Diabetes care.

[39]  Alfonso T. Perez,et al.  A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. , 2005, Diabetes care.

[40]  E. Feskens,et al.  Interactions of dietary fat intake and the hepatic lipase -480C-->T polymorphism in determining hepatic lipase activity: the Hoorn Study. , 2005, The American journal of clinical nutrition.

[41]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[42]  H. Ginsberg.  Insulin resistance and cardiovascular disease. , 2000, The Journal of clinical investigation.

[43]  Cm Williams,et al.  The quantitation of lipoprotein lipase mRNA in biopsies of human adipose tissue, using the polymerase chain reaction, and the effect of increased consumption of n-3 polyunsaturated fatty acids , 1999, European Journal of Clinical Nutrition.

[44]  P. Stacpoole,et al.  Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet. , 1998, Journal of lipid research.

[45]  S M Grundy,et al.  Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. , 1997, Circulation.

[46]  K. Evans,et al.  Effect of storage at 4 degrees C and -20 degrees C on lipid, lipoprotein, and apolipoprotein concentrations. , 1995, Clinical chemistry.

[47]  P. Royston.  A pocket-calculator algorithm for the Shapiro-Francia test for non-normality: an application to medicine. , 1993, Statistics in medicine.

[48]  C. Salmond,et al.  Stability of total cholesterol, high-density-lipoprotein cholesterol, and triglycerides in frozen sera. , 1986, Clinical chemistry.

[49]  OUP accepted manuscript , 2021, The Journal of Nutrition.

[50]  T. A. Jacobson,et al.  Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. , 2012, Journal of clinical lipidology.

[51]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.